Report Detail
Global (United States, European Union and China) Conjugate Vaccine Market Research Report 2019-2025
- RnM3695462 |
- 26 August, 2019 |
- Global |
- 123 Pages |
- QYResearch |
- Pharma & Healthcare
Conjugate vaccines are formed by covalently bonding a weak antigen to the strong antigen. It boosts the hosts’ immune response. Conjugate vaccines are germ specific and can identify targeted germ only, so it can be used as a preventative measure to provide additional protection. Conjugate vaccines are used to treat Hib (Haemophilus influenzae type b) disease, Hepatitis B, HPV (Human papillomavirus), Whooping cough (part of the DTaP combined vaccine), Pneumococcal disease, Meningococcal disease, and Shingles.
The rising occurrence of diseases caused by microorganisms, increasing awareness about prevention of infectious diseases, and an increasing number of regulatory approvals to the vaccines are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by top players such as new product launches are contributing to the growth of the market.
In 2019, the market size of Conjugate Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Conjugate Vaccine.
This report studies the global market size of Conjugate Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Conjugate Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GlaxoSmithKline
Pfizer
Merck
Sanofi Pasteur
CSL
Emergent BioSolutions
Johnson & Johnson
Medimmune
Astellas Pharma
Serum Institute of India
Bavarian Nordi
Mitsubishi Tanabe Pharma
Daiichi Sankyo Company
Fablife
SutroVax
Sinovac Biotech
Market Segment by Product Type
Monovalent
Multivalent
Market Segment by Application
Hospitals
Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Conjugate Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Conjugate Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Conjugate Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Conjugate Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Monovalent
- 1.3.3 Multivalent
- 1.4 Market Segment by Application
- 1.4.1 Global Conjugate Vaccine Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Conjugate Vaccine Market Size
- 2.1.1 Global Conjugate Vaccine Revenue 2014-2025
- 2.1.2 Global Conjugate Vaccine Sales 2014-2025
- 2.2 Conjugate Vaccine Growth Rate by Regions
- 2.2.1 Global Conjugate Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Conjugate Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Conjugate Vaccine Sales by Manufacturers
- 3.1.1 Conjugate Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Conjugate Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Conjugate Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Conjugate Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Conjugate Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Conjugate Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Conjugate Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Conjugate Vaccine Market
- 3.6 Key Manufacturers Conjugate Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Monovalent Sales and Revenue (2014-2019)
- 4.1.2 Multivalent Sales and Revenue (2014-2019)
- 4.2 Global Conjugate Vaccine Sales Market Share by Type
- 4.3 Global Conjugate Vaccine Revenue Market Share by Type
- 4.4 Conjugate Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Conjugate Vaccine Sales by Application
6 United States
- 6.1 United States Conjugate Vaccine Breakdown Data by Company
- 6.2 United States Conjugate Vaccine Breakdown Data by Type
- 6.3 United States Conjugate Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Conjugate Vaccine Breakdown Data by Company
- 7.2 European Union Conjugate Vaccine Breakdown Data by Type
- 7.3 European Union Conjugate Vaccine Breakdown Data by Application
8 China
- 8.1 China Conjugate Vaccine Breakdown Data by Company
- 8.2 China Conjugate Vaccine Breakdown Data by Type
- 8.3 China Conjugate Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Conjugate Vaccine Breakdown Data by Company
- 9.2 Rest of World Conjugate Vaccine Breakdown Data by Type
- 9.3 Rest of World Conjugate Vaccine Breakdown Data by Application
- 9.4 Rest of World Conjugate Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Conjugate Vaccine Sales by Countries
- 9.4.2 Rest of World Conjugate Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 GlaxoSmithKline
- 10.1.1 GlaxoSmithKline Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Conjugate Vaccine
- 10.1.4 Conjugate Vaccine Product Introduction
- 10.1.5 GlaxoSmithKline Recent Development
- 10.2 Pfizer
- 10.2.1 Pfizer Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Conjugate Vaccine
- 10.2.4 Conjugate Vaccine Product Introduction
- 10.2.5 Pfizer Recent Development
- 10.3 Merck
- 10.3.1 Merck Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Conjugate Vaccine
- 10.3.4 Conjugate Vaccine Product Introduction
- 10.3.5 Merck Recent Development
- 10.4 Sanofi Pasteur
- 10.4.1 Sanofi Pasteur Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Conjugate Vaccine
- 10.4.4 Conjugate Vaccine Product Introduction
- 10.4.5 Sanofi Pasteur Recent Development
- 10.5 CSL
- 10.5.1 CSL Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Conjugate Vaccine
- 10.5.4 Conjugate Vaccine Product Introduction
- 10.5.5 CSL Recent Development
- 10.6 Emergent BioSolutions
- 10.6.1 Emergent BioSolutions Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Conjugate Vaccine
- 10.6.4 Conjugate Vaccine Product Introduction
- 10.6.5 Emergent BioSolutions Recent Development
- 10.7 Johnson & Johnson
- 10.7.1 Johnson & Johnson Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Conjugate Vaccine
- 10.7.4 Conjugate Vaccine Product Introduction
- 10.7.5 Johnson & Johnson Recent Development
- 10.8 Medimmune
- 10.8.1 Medimmune Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Conjugate Vaccine
- 10.8.4 Conjugate Vaccine Product Introduction
- 10.8.5 Medimmune Recent Development
- 10.9 Astellas Pharma
- 10.9.1 Astellas Pharma Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Conjugate Vaccine
- 10.9.4 Conjugate Vaccine Product Introduction
- 10.9.5 Astellas Pharma Recent Development
- 10.10 Serum Institute of India
- 10.10.1 Serum Institute of India Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Conjugate Vaccine
- 10.10.4 Conjugate Vaccine Product Introduction
- 10.10.5 Serum Institute of India Recent Development
- 10.11 Bavarian Nordi
- 10.12 Mitsubishi Tanabe Pharma
- 10.13 Daiichi Sankyo Company
- 10.14 Fablife
- 10.15 SutroVax
- 10.16 Sinovac Biotech
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Conjugate Vaccine Sales Channels
- 11.2.2 Conjugate Vaccine Distributors
- 11.3 Conjugate Vaccine Customers
12 Market Forecast
- 12.1 Global Conjugate Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Conjugate Vaccine Sales Forecast by Type
- 12.3 Global Conjugate Vaccine Sales Forecast by Application
- 12.4 Conjugate Vaccine Forecast by Regions
- 12.4.1 Global Conjugate Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Conjugate Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Conjugate Vaccine. Industry analysis & Market Report on Conjugate Vaccine is a syndicated market report, published as Global (United States, European Union and China) Conjugate Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Conjugate Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
